BioStock: Magle Group launches multicenter trial with pancreatic leakage indicator

Magle Group has partnered with Heidelberg University Hospital in Germany to launch a study evaluating the effectiveness of SmartPAN in pancreatic surgery. This post-market study aims to further explore SmartPAN’s ability to detect and prevent pancreatic fluid leakage following surgical procedures.

Read the article at biostock.se:

https://www.biostock.se/en/2025/03/magle-group-launches-multicenter-trial-with-pancreatic-leakage-indicator/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/